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Previously we used mass spectrometry to show that
the yeast G protein  subunit Gpa1 is ubiquitinated at
Lys-165, located within a subdomain not present in
other G proteins (Marotti, L. A., Jr., Newitt, R., Wang,
Y., Aebersold, R., and Dohlman, H. G. (2002) Biochemistry
41, 5067–5074). Here we describe the functional role of
Gpa1 ubiquitination. We find that Gpa1 expression is
elevated in mutants deficient in either proteasomal or
vacuolar protease function. Vacuolar protease pep4 mu-
tants accumulate monoubiquitinated Gpa1, and much of
the protein is localized within the vacuolar compart-
ment. In contrast, proteasome-defective rpt6/cim3 mu-
tants accumulate polyubiquitinated Gpa1, and in this
case the protein exhibits cytoplasmic localization. Cells
that lack Ubp12 ubiquitin-processing protease activity
accumulate both mono- and polyubiquitinated forms of
Gpa1. In this case, Gpa1 accumulates in both the cyto-
plasm and vacuole. Finally, a Gpa1 mutant that lacks the
ubiquitinated subdomain remains unmodified and is
predominantly localized at the plasma membrane.
These data reveal a strong relationship between the
extent of ubiquitination and trafficking of the G protein
 subunit to its site of degradation.
Many sensory and chemical stimuli act via cell surface re-
ceptors and intracellular G proteins. In yeast, G protein-cou-
pled receptors initiate a signaling cascade that leads to mor-
phological changes, new gene transcription, cell cycle arrest,
and eventually, mating. Mating, the process by which a and 
haploid cells fuse to form the a/ diploid, is initiated by cell
type-specific peptide pheromones. Haploid a-type cells secrete
a-factor pheromone, which binds to specific receptors found
only on -type cells, whereas -type cells secrete -factor that
acts exclusively on a cells (1).
Most components of the pheromone-signaling cascade in
yeast have been identified through the isolation of gene muta-
tions that produce an unresponsive sterile (ste) phenotype.
Genes required for mating include the receptors for -factor
(STE2) and a-factor (STE3), the G protein  (STE4) and 
(STE18) subunits, G protein effectors (STE5, STE20, CDC24),
and downstream protein kinases (STE20, STE11, STE7,
FUS3, KSS1) as well as a transcription factor (STE12). The G
protein  subunit serves primarily to regulate the levels of free
G. Cells lacking the G subunit gene (GPA1) cannot seques-
ter G and so are permanently activated (2, 3). The G sub-
unit can also modulate signaling indirectly through binding to
the polyribosome-associated protein Scp160 (4).
As with other G protein systems, pheromone binding to its
receptor promotes the exchange of GTP for GDP on the G
subunit followed by dissociation of G from the G subunit
complex (5). The dissociated subunits in turn transmit and
amplify the signal to effector proteins that produce an intra-
cellular response. Signaling persists until GTP is hydrolyzed to
GDP and the subunits reassemble. Given their position as
intermediaries between signal detectors (receptors) and signal
transmitters (effectors), G proteins are well positioned to serve
as targets of regulation. Particularly important in this role is
the regulator of G protein signaling protein Sst2, which atten-
uates the pheromone signal by accelerating Gpa1 GTP hydrol-
ysis and thereby reducing the lifetime of the activated G pro-
tein (6, 7).
There is growing evidence that G protein signaling compo-
nents are also regulated by post-translational modifications (8).
Recent attention has focused on ubiquitination, the process by
which a ubiquitin polypeptide is covalently attached to specific
target proteins (9). Once a protein is ubiquitinated, ubiquitin
can itself be ubiquitinated, resulting in the formation of a
polyubiquitin chain. Polyubiquitinated substrates are then
captured by the proteasome protease complex and rapidly de-
graded (10). Of the pheromone signaling components in yeast,
ubiquitination has been reported for the G protein Gpa1 (11,
12), the regulator of G protein signaling protein Sst2 (13) and
the effector kinase Ste7 (14, 15). Ubiquitination of both Ste7
and Sst2 are induced by pheromone, and these modifications
are thought to represent feedback loops leading to pheromone
desensitization and resensitization, respectively (13–15).
Ubiquitination has also been described for the pheromone
receptors Ste2 and Ste3 (16, 17). However, in this instance the
proteins are monoubiquitinated instead of polyubiquitinated
and degraded by the vacuole (the yeast counterpart to the
lysosome) instead of by the proteasome (16–19). This discovery
led to the hypothesis that ubiquitination is primarily a protein-
trafficking signal, and monoubiquitination promotes degrada-
tion only by allowing the substrate to undergo internalization
and delivery to the vacuole compartment (20).
Recently we used mass spectrometry to identify the ubiquiti-
nation site of Gpa1 in vivo (11). The site of modification (Lys-
165) lies within the -helical domain of the G protein and, more
specifically, within a 110-residue subdomain not found in other
* This work was supported by National Institutes of Health Grants
GM059167 and GM055316 (to H. G. D.). The costs of publication of this
article were defrayed in part by the payment of page charges. This
article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
§ A fellow of the American Heart Association.
 A trainee of the Yale Interdepartmental Neuroscience Program.
‡‡ A trainee of the University of North Carolina Interdisciplinary
Program in Biomedical Sciences.
§§ To whom correspondence should be addressed: Dept. of Biochem-
istry and Biophysics, University of North Carolina, 405 Mary Ellen
Jones Bldg., Campus Box 7260, Chapel Hill, NC 27599-7260. Tel.:
919-843-6894; Fax: 919-966-2852; E-mail: henrik_dohlman@med.unc.
edu.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 280, No. 1, Issue of January 7, pp. 284–291, 2005
© 2005 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org284
This is an Open Access article under the CC BY license.
G subunits. Here we show that the Gpa1 subdomain under-
goes both mono- and polyubiquitination. Monoubiquitinated
Gpa1 is targeted to the vacuole, whereas polyubiquitinated
Gpa1 is delivered to the proteasome. These findings reveal that
G protein trafficking can function independently of substrate
targeting signals and, instead, depends solely on the extent of
substrate ubiquitination.
MATERIALS AND METHODS
Strains and Plasmids—Standard methods for the growth, mainte-
nance, and transformation of yeast and bacteria and for the manip-
ulation of DNA were used throughout (21). Yeast Saccharomyces
cerevisiae strains used in this study were BY4741 (MATa leu2
met15 his3 ura3), BY4741-derived mutants lacking PEP4 or
UBP12 (disrupted using the KanMX G418-resistance marker, from
Research Genetics, Huntsville, AL), MHY753 (MATa his3-200
leu21 ura3-52 lys2-801 trp163 ade2-101), MHY754 (MHY753,
cim3-1), CRY1 (MATa ura3-1 leu2,3-112 his3-11 trp1-1 ade2-1oc can1-
100), CB007–1 (CRY1, pep4-2::HIS3 prb1::LEU2) (provided by
Linda Hicke, Northwestern University) (22), and YGS5 (MATa
ura3-52 lys2 ade2oc trp1 leu2-1 gpa1::hisG ste11ts) (23). STE2 was
disrupted in BY4741 and BY4741-derived pep4 mutant strains by
single-step gene replacement with ste2::HIS3 (this work).
Yeast shuttle plasmids used here were pRS316 (CEN, ampR, URA3),
pRS406 (ampR, URA3) (24), pRS316-GPA1, which contains GPA1 under
the control of its native promoter (23), pAD4M (2 m, ampR, LEU2,
ADH1 promoter/terminator, from Peter McCabe, Onyx Pharmaceuti-
cal), pAD4M-GPA1 (23), pND747 (2 m, ampR, URA3, Myc-tagged
ubiquitin under the control of the CUP1 promoter, from Nicholas Davis,
Wayne State University) (25), and pRS425-FUS1-lacZ (26). pRS316-
GPA1128–236 was constructed by replacing the 1.5-kbp HindIII-HindIII
fragment with a 1170-bp PCR product, generated using GPA1 as tem-
plate. The forward primer 5-CCC AAG CTT TAA TTC ACG AAG ACA
TTG CTA AGG CAA TAA AGC AAC TTT GG-3 disrupts and regener-
ates the GPA1 HindIII site; the reverse primer 5-AGG TCG ACG GTA
TCG ATA AGC-3 flanks the multiple cloning site HindIII upstream of
the gene insert within pRS316. pAD4M-GPA1128–236 was constructed
by PCR amplification of GPA1128–236 using primers 5-ACG CGT CGA
CAT GGG GTG TAC AGT GAG TAC GCA AAC AAT A-3 and 5-CGA
GCT CTC ATA TAA TAC CAA TTT TTT TAA GGT TTT GCT-3,
engineered with SalI and SacI sites, and subcloning into the SalI/SacI
sites within the multiple cloning site of the pAD4M vector. Note that
positions 127 and 236 both encode Leu. A triple-FLAG epitope tag was
placed at the C terminus of Ubp12 (UBP12-FLAG) by PCR amplifica-
tion and subcloning into pYES2.1/V5-His-TOPO (2 m, URA3, GAL1
promoter, CYC1 terminator) (Invitrogen) to yield plasmid pYES-
UBP12-FLAG. PCR primers were 5-CCC AAG CTT CCA GAA TGG
GTT CTT CAG ATG TTT CAA GTC-3 and 5-G TTA CTT GTC ATC
GTC ATC TTT ATA ATC CTT GTC ATC GTC ATC TTT ATA ATC CTT
GTC ATC GTC ATC TTT ATA ATC AAG CTT TTC TGG CGA TTC TAG
TGT CAC-3.
The Gpa1-green fluorescent protein (GFP)1 fusion was constructed
by PCR amplification of the GPA1 gene, digested with XbaI and ClaI,
and subcloned into the corresponding sites of yeast-enhanced GFP-
containing plasmid pUG35 (CEN, URA3, MET25 promoter, CYC1 ter-
minator) (27). PCR primers used were 5-CCT GCA GCC CGG GGG
ATC CAC TAG TCT AGA-3 (forward) and 5-ACA TCG ATT ATA ATA
CCA ATT TTT TTA AGG TTT TGC TGG ATC-3 (reverse) and included
unique XbaI and ClaI restriction sites. A cassette containing the pro-
moter GPA1-GFP and terminator was digested with SacI and KpnI and
subcloned into the corresponding sites of integrating vector pRS406
to yield pRS406-GPA1-GFP. The resulting plasmid was linearized
with HindIII (a site unique to GPA1) to direct gene integration.
GPA1128–236-GFP was constructed as described for GPA1-GFP except
for the use of a different forward primer (5-GGT CTA GAC ATG GGG
TGT ACA GTG AGT ACG-3) and GPA1128–236 as the template.
Growth, Transcription, Degradation, and Ubiquitination Bioas-
says—The pheromone-dependent growth inhibition (halo) and reporter-
transcription assays were conducted as described previously (26). Gpa1
expression and ubiquitination was monitored as described previously
(11). To monitor the loss of Gpa1, cultures were treated with cyclohex-
imide (10 g/ml in 0.1% ethanol, final concentrations) for up to 120 min,
as described previously (28). Growth was stopped at mid-log phase
(A600 nm  1) by the addition of 10 mM NaN3 and transferred to an ice
bath. Cells were centrifuged and washed with 10 mM NaN3, and the cell
pellet was resuspended directly in boiling SDS-PAGE sample buffer
(62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 1% 2-mercaptoeth-
anol, 0.0005% bromphenol blue) for 10 min. The samples were then
subjected to glass bead homogenization, clarified by microcentrifuga-
tion, resolved by SDS-polyacrylamide gel electrophoresis, and trans-
ferred to nitrocellulose. The membrane was probed with antibodies to
Gpa1 at 1:1,000 (29), Ste4 at 1:2,000 (from Duane Jenness, University
of Massachusetts), or Pgk1 at 1:75,000 (from Jeremy Thorner, Univer-
sity of California Berkeley). Immunoreactive species were visualized by
enhanced chemiluminescence detection (Pierce) of horseradish peroxi-
dase-conjugated anti-rabbit IgG (Bio-Rad).
Immunoprecipitation—The association of Gpa1 and Ubp12 was ex-
amined by immunoprecipitation of FLAG-tagged Ubp12 and immuno-
blotting with anti-Gpa1 antibodies. Cells (50 ml) co-transformed with
plasmids pAD4M-GPA1 and pYES-UBP12-FLAG were grown to A600 nm
 1, harvested, and resuspended in 550 l of lysis buffer (50 mM NaPO4,
pH 7.5, 400 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.5 mM dithio-
threitol, 25 mM NaF, 25 mM glycerophosphate, 1 mM sodium orthovana-
date, 10 mM N-ethylmaleimide, 5 mM phenylmethylsulfonyl fluoride,
and one pellet of complete EDTA-free protease inhibitor mixture (Roche
Applied Science)). This and all subsequent manipulations were carried
out at 4 °C. Cells were subjected to glass bead vortex homogenization
for 30 s, repeated 8 times, and centrifuged twice at 6000  g for 5 min
and 25 min. Lysates were incubated for 2 h with a bead volume of 10 l
of anti-FLAG M2 affinity resin (Sigma) equilibrated in lysis buffer.
Immunoprecipitates were collected by centrifugation at 1000  g for
30 s, and pellets were washed with 1 ml of lysis buffer for 3 min,
repeated 4 times before final resuspension in 30 l of 2 SDS-PAGE
sample buffer. Each sample was resolved by 7.5% polyacrylamide gel
electrophoresis and immunoblotting with anti-Gpa1 polyclonal antibod-
ies at 1:1000 or anti-FLAG monoclonal antibodies at 1:2000.
Microscopy Analysis—Cells expressing single-copy, integrated GFP-
tagged gene fusions were visualized by differential interference con-
trast (DIC) and fluorescence microscopy using a Nikon eclipse E600EN,
photographed with a Hamamatsu digital camera, and analyzed with
MetaMorph Version 5.0 software.
RESULTS
Many cellular proteins are polyubiquitinated and degraded
by the proteasome. However, a handful of proteins are instead
monoubiquitinated and delivered to the vacuole. This alterna-
tive pathway was first documented for the yeast G protein-
coupled receptors Ste2 and Ste3 (16, 17, 19). Both of these
receptors are monoubiquitinated in response to prolonged
treatment with pheromone, and once modified they are rapidly
endocytosed and degraded within the vacuole compartment
(16–18). Gpa1 is also monoubiquitinated (11, 12), suggesting
that this protein is likewise degraded by the vacuole. To test
this supposition we examined the fate of Gpa1 in pep4 mutant
cells, which lack vacuolar protease function (30). Pep4, also
known as proteinase A, is a saccharopepsin aspartyl protease
required for activation of degradative enzymes within the vac-
uole. Cell lysates from wild-type and pep4 mutant cells were
resolved by gel electrophoresis and immunoblotting, and the
abundance of Gpa1 was monitored using anti-Gpa1 antibodies.
Gpa1 normally migrates as a doublet of 54 and 56 kDa (repre-
senting myristoylated and non-myristoylated species, respec-
tively) (29, 31). As shown in Fig. 1, steady state levels of Gpa1
were 2-fold higher in the vacuolar protease-deficient pep4
mutant strain. Expression of Ste4 (G) was also elevated in
these mutants. We then measured the abundance of the G
protein  and  subunits in a temperature-sensitive cim3-1
mutant, which at the restrictive temperature has severely im-
paired proteasomal protease activity (22). Cim3 (also known as
Rpt6) is a subunit of the proteasome 19 S regulatory particle,
which confers specificity for ubiquitinated proteins for presen-
tation to the proteasome proteolytic subunits (32). Gpa1 (but
not Ste4) expression was enriched in the cim3-1 mutant, sug-
gesting that the G protein can also be degraded by the pro-
1 The abbreviations used are: GFP, green fluorescent protein; DIC,
differential interference contrast; UBP, ubiquitin-specific processing
protease.
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teasome (Fig. 1) (11). These findings suggest that Gpa1 can be
degraded either by the vacuole or the proteasome, whereas
Ste4 is degraded primarily by the vacuole.
Whereas degradation by the proteasome typically requires
substrate polyubiquitination, vacuolar degradation of Ste2 is
triggered by monoubiquitination (16). If Gpa1 is degraded by
the vacuole, defects in this pathway should result in an accu-
mulation of the monoubiquitinated form of the protein. Con-
versely, if Gpa1 is degraded by the proteasome, defects in that
pathway should result in an accumulation of polyubiquitinated
Gpa1. To test this we overexpressed Gpa1 in mutant strains
deficient in either vacuolar protease or proteasome activity.
Overexpression was necessary for this experiment in order to
detect the minor ubiquitinated species. In wild-type cells, Gpa1
migrated at 54 and 56 kDa (Fig. 2). In the vacuolar-protease-
deficient pep4 strain an additional monoubiquitinated species
migrated near 63 kDa (Fig. 2A) (11, 12). In contrast, the pro-
teasome-deficient cim3-1 strain accumulated a ladder of high
molecular weight bands representing polyubiquitinated Gpa1
(Fig. 2B) (11, 12). These results support the suggestion that
Gpa1 is degraded by two routes; one entails monoubiquitina-
tion and delivery to the vacuole, whereas the second requires
polyubiquitination and delivery to the proteasome.
The vacuolar degradation pathway is used by the pheromone
receptor and, as shown here, by the G protein  subunit Gpa1.
Monoubiquitination of the receptor is enhanced by pheromone.
Because the receptor and G protein bind to one another, we
investigated whether monoubiquitination and/or degradation of
both substrates occur in a coordinated manner. We first exam-
ined whether monoubiquitination of Gpa1 was affected by pro-
longed exposure to pheromone and consistently found no differ-
ence (data not shown) (11). Second, we tested whether
monoubiquitination of Gpa1 was affected by deletion of the re-
ceptor gene STE2 and again found no difference (compare pep4
and ste2/pep4 mutants, Fig. 2, A and C). These data indicate
that Gpa1 monoubiquitination as well as vacuolar sorting occurs
independently of receptor binding or pheromone occupancy.
It was shown previously that the pheromone receptor accu-
mulates in the vacuole of cells deficient in vacuolar protease
activity (16, 18). To determine whether Gpa1 is likewise deliv-
ered to the vacuole we compared the distribution of the protein
(expressed as a chromosomally integrated GFP fusion) in wild-
type and pep4 mutant strains. As shown in Fig. 3, Gpa1 in
wild-type cells was detected at the plasma membrane. In con-
trast, Gpa1 in the pep4 mutant was visible at the plasma
membrane and also within the large vacuolar compartment,
which is easily identified as the most prominent organelle
within the cell. Taken together these data indicate that Gpa1,
like Ste2, is monoubiquitinated and degraded by the vacuole.
Whereas the receptor is delivered to the vacuole upon phero-
mone stimulation, the G protein is delivered in a constitutive or
pheromone-independent manner.
Most cytoplasmic proteins are polyubiquitinated and deliv-
ered to the proteasome complex. Thus, we anticipated that
polyubiquitinated Gpa1 would not be targeted to the vacuole.
To test this prediction we examined the subcellular distribu-
tion of Gpa1-GFP in the proteasome-defective cim3-1 mutant
strain, which accumulates the polyubiquitinated form of the
substrate. As shown in Fig. 3, Gpa1 in the cim3-1 mutant was
predominantly localized in the cytoplasm and, in contrast to
pep4, was largely excluded from the vacuole. We presume that
the cytoplasmic staining represents Gpa1 associated with or en
route to the proteasome complex. Taken together these data
suggest that Gpa1 is delivered to the proteasome when poly-
ubiquitinated but not when monoubiquitinated. Conversely,
Gpa1 is delivered to the vacuole when monoubiquitinated but
not when polyubiquitinated.
To further corroborate these results, we asked whether ex-
pression of both the mono- and polyubiquitinated forms of
Gpa1 might direct the protein to both the vacuolar compart-
ment and the cytoplasm. To this end we used two methods in
combination, one to stabilize the monoubiquitinated form of
Gpa1 and a second designed to stabilize the polyubiquitinated
form of the protein. The first approach was to overexpress
Myc-tagged ubiquitin through the use of a copper inducible
promoter (from CUP1). Myc-ubiquitinated substrates are de-
graded more slowly and, therefore, can be detected more easily
in vivo (33). Copper-induction of Myc-ubiquitin promoted the
accumulation of monoubiquitinated Gpa1, as shown previously
(11, 12) (Fig. 4A). The second approach was to delete the ubiq-
uitin-specific processing protease (UBP) that removes ubiq-
uitin from Gpa1. This approach is similar to one used in our
earlier analysis of the effector kinase Ste7 (14, 15). By screen-
ing mutants that lack each of 16 ubiquitin-processing proteases
(or UBPs) we had found one (ubp3) that resulted in the
accumulation of polyubiquitinated Ste7. We conducted a simi-
lar screen of the UBP deletion mutants and found another,
ubp12, that specifically accumulated ubiquitinated Gpa1
(Fig. 4A and data not shown). Moreover, immunoprecipitation
of Ubp12 resulted in the co-purification of Gpa1, further sug-
gesting that Gpa1 ubiquitination is regulated directly by
Ubp12 (Fig. 4B). By overexpressing Myc-ubiquitin in a ubp12
strain, we could achieve an increase in both mono- and polyu-
biquitinated forms of Gpa1 (Fig. 4A, fourth lane).
We then asked how mono- and polyubiquitination affects
Gpa1 localization. To this end we examined the subcellular
distribution of Gpa1-GFP in ubp12 mutant cells after induc-
tion of Myc-ubiquitin. Whereas Gpa1 is normally localized at
the plasma membrane, overexpression of Myc-ubiquitin in the
ubp12 strain led to a redistribution of Gpa1 to the vacuolar
compartment as well as to the cytoplasm (Fig. 5). Thus, under
conditions where Gpa1 is polyubiquitinated and monoubiquiti-
nated in the same cell, the protein is directed to both the
vacuolar compartment and the cytoplasm. Stated differently,
the distribution of Gpa1 in this case is an amalgamation of the
distribution seen in pep4 and cim3-1 cells.
We then wished to determine the fate of Gpa1 that is not
ubiquitinated. Initially we examined the localization of
Gpa1K165R, which lacks the primary site of in vivo ubiquitina-
tion (11). However, we found the subcellular distribution of
FIG. 1. Gpa1 is degraded by both the proteasomal and vacuo-
lar protease pathways. Whole cell extracts were prepared from a
vacuolar protease mutant (pep4-2, prb1::LEU2, or pep4::KanMX with
similar results; data not shown), a temperature-sensitive proteasomal
protease defective mutant (cim3-1) grown at the restrictive tempera-
ture of 37 °C for 4 h, and isogenic wild-type strains. Samples were
resolved by 7.5% SDS-PAGE and detected by immunoblotting (IB) with
antibodies against Gpa1 (G), Ste4 (G), or Pgk1 (loading control),
as indicated.
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Gpa1K165R was similar to that of the wild-type protein (data not
shown). We presume that one or more secondary sites are
modified when Lys-165 is altered, and this accounts for the
residual ubiquitination as well as the unaltered subcellular
localization of the mutant protein. We also reasoned that any
secondary sites are likely to be clustered within the same
110-residue subdomain that contains Lys-165. To test this pos-
sibility we constructed and analyzed a mutant form of the
protein that lacks the ubiquitinated subdomain altogether
(Gpa1128–236). The position of the internal deletion was chosen
based on a sequence alignment of Gpa1 with Gi and Gt, two
mammalian proteins that lack the subdomain and for which
crystal structures are available (34, 35).
We first compared the ubiquitination of wild-type Gpa1 and
Gpa1128–236. Once again we expressed Myc-ubiquitin in order
to improve detection of the ubiquitinated product. The wild-
type protein migrated as a doublet of 54 and 56 kDa as a
monoubiquitinated species of 63 kDa and as a higher molecular
mass polyubiquitinated species near the top of the gel. Copper-
induced expression of Myc-ubiquitin further increased detec-
tion of the monoubiquitinated species (Fig. 6). In comparison,
Gpa1128–236 migrated as a doublet of 42 and 44 kDa, close to
the size predicted for the unmodified mutant product. In this
case, however, there were no additional bands after copper
induction and no specific bands of the size expected for either
monoubiquitinated or polyubiquitinated forms of the protein
(Fig. 6). These results suggest that ubiquitination is largely
blocked by deletion of the 110-residue subdomain in Gpa1.
We then asked whether the ubiquitination subdomain is
required for Gpa1 function in vivo. Initially we measured pher-
omone sensitivity using a standard growth arrest assay. In this
method a nascent lawn of cells is exposed to a point source of
-factor. As the lawn develops, a zone of growth inhibition
appears, the size of which reflects the sensitivity of the cells to
pheromone-induced growth arrest. As shown in Fig. 7A, cells
expressing Gpa1128–236 exhibited a smaller and more turbid
zone of growth inhibition compared with the wild-type protein,
indicating a diminished pheromone response. We also com-
pared Gpa1128–236 and Gpa1 activity using a reporter-tran-
scription assay consisting of the pheromone-inducible FUS1
promoter driving expression of lacZ (-galactosidase) (26). As
shown in Fig. 7B, cells expressing Gpa1128–236 exhibited a
30% reduction in the maximum pheromone response, consist-
ent with the reduced growth arrest response described above.
Thus, deletion of the ubiquitination subdomain appears to en-
hance the ability of Gpa1 to block the G-mediated signal,
FIG. 2. Accumulation of ubiquitinated Gpa1 in vacuolar and proteasomal protease-deficient mutant strains. A, a vacuolar protease-
deficient (pep4::KanMX) mutant and the isogenic wild-type strain were transformed with a plasmid containing wild-type GPA1 (pAD4M-GPA1).
Plasmid-borne overexpression of Gpa1 was required to detect the minor ubiquitinated species. Whole cell extracts were resolved by 7.5%
SDS-PAGE and immunoblotting with anti-Gpa1 antibodies. B, a proteasomal protease defective (cim3-1) mutant and the isogenic wild-type strain
were transformed with plasmid pAD4M-GPA1, grown at the restrictive temperature of 37 °C for 4 h, and analyzed by immunoblotting with
anti-Gpa1 antibodies as described above. C, the same strains as in panel A, except lacking the -factor receptor gene STE2. Arrows indicate the
mobility of unmodified Gpa1, monoubiquitinated Gpa1 (ubi-Gpa1), and polyubiquitinated Gpa1 (ubin-Gpa1).
FIG. 3. Mislocalization of Gpa1 in
vacuolar and proteasomal protease-
deficient mutant strains. Vacuolar pro-
tease-deficient (pep4::KanMX), proteaso-
mal protease-deficient (cim3-1), and the
isogenic wild-type strains were trans-
formed with an integrating plasmid
(pRS406-GPA1-GFP) containing the na-
tive GPA1 promoter and gene fused to the
gene encoding yeast-enhanced green fluo-
rescent protein. Cells were grown to mid-
log phase at 30 °C and visualized by DIC
and fluorescence microscopy. Cells ex-
pressing Gpa1 alone exhibited negligible
background autofluorescence (data not
shown).
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resulting in diminished growth arrest and transcription-induc-
tion responses. Stated differently, the Gpa1128–236 mutant
exhibits a moderate gain-of-function phenotype.
Gpa1128–236 was expressed at slightly higher steady state
levels than wild-type Gpa1. This difference persisted long after
treatment with the protein synthesis inhibitor cycloheximide
(Fig. 7C). However expression of the mutant did diminish over
time, suggesting that some degradation can occur even in the
absence of ubiquitination. Apparently any reduction in Gpa1
degradation is sufficient to cause an increase in steady state
expression but not large enough to be easily detected after
exposure to cycloheximide.
Because either mono- or polyubiquitination promotes a re-
distribution of Gpa1 away from the plasma membrane, the
absence of ubiquitination would most likely favor Gpa1 local-
ization to the plasma membrane. Indeed, Gpa1128–236 was
present almost exclusively at the plasma membrane even when
expressed in the protease-deficient pep4 and ubp12 mutants
(Fig. 8). Because overexpression of Gpa1 diminishes G-me-
diated signaling, increased plasma membrane localization
could easily account for the diminished pheromone response in
cells that express Gpa1128–236. This seems more likely than an
alteration in subunit interaction since the ubiquitinated sub-
domain lies within the helical domain of the protein, and this
FIG. 4. Accumulation of ubiquitinated Gpa1 in ubiquitin-proc-
essing protease-deficient mutant cells. A, a ubiquitin-processing
protease-deficient (ubp12::KanMX) mutant and isogenic wild-type
strain were co-transformed with plasmids containing Gpa1 (pAD4M-
GPA1) and Myc-ubiquitin under the control of the copper-inducible
CUP1 promoter (pND747). Mid-log phase cells were treated with 100
M CuSO4 for 4 h as indicated and then collected and resolved by 7.5%
SDS-PAGE and immunoblotting using anti-Gpa1 antibodies. Arrows
indicate the mobility of unmodified Gpa1 as well as the monoubiquiti-
nated (ubi-Gpa1) and polyubiquitinated (ubin-Gpa1) species. B, wild-
type cells were co-transformed with plasmids containing Gpa1
(pAD4M-GPA1) and FLAG epitope-tagged Ubp12 (pYES-UBP12-
FLAG) or the empty parent vector. Ubp12-FLAG was immunoprecipi-
tated (IP) with M2 anti-FLAG resin, and the copurification of Gpa1 with
Ubp12 was detected by immunoblotting (IB) with anti-Gpa1 and anti-
FLAG antibodies. An immunoblot of whole cell extracts (WCE) is also
shown to confirm equal expression of Gpa1.
FIG. 5. Accumulation of Gpa1 within the cytoplasm and vacu-
ole of ubiquitin-processing protease-deficient mutant cells. A
ubiquitin-processing protease deficient (ubp12::KanMX) mutant and
isogenic wild-type strain were transformed with an integrating plasmid
(pRS406-GPA1-GFP) encoding Gpa1 fused to GFP and a plasmid con-
taining Myc-ubiquitin under the control of the copper-inducible CUP1
promoter (pND747). Cells were treated with CuSO4 for 4 h and visual-
ized at mid-log phase by DIC and fluorescence microscopy. Cells ex-
pressing Gpa1 alone exhibited negligible background autofluorescence
(data not shown).
FIG. 6. Removal of the 110 amino acid subdomain eliminates
Gpa1 ubiquitination in vivo. Wild-type cells (BY4741) were co-trans-
formed with a plasmid (pAD4M) containing wild-type GPA1 or a GPA1
mutant lacking the ubiquitination subdomain (Gpa1128–236) and a
plasmid containing Myc-ubiquitin under the control of the copper-in-
ducible CUP1 promoter (pND747). Mid-log phase cells were treated
with CuSO4 for 4 h, then collected and resolved by 7.5% SDS-PAGE and
immunoblotting using anti-Gpa1 antibodies. Arrows indicate the mo-
bility of unmodified Gpa1 as well as the monoubiquitinated (ubi-Gpa1)
and polyubiquitinated (ubin-Gpa1) species. Other bands (*) appear to be
non-specifically recognized (i.e. cross-react with anti-Gpa1 antibodies),
since they are also present at equal levels in extracts from cells that
express only the endogenous Gpa1 (left panel) or lack Gpa1 altogether
(e.g. diploid cells, data not shown), and none is induced by copper
treatment. The left panel was exposed longer to show bands that are
non-specifically recognized by the Gpa1 antibody.
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domain has no contact with the guanine nucleotide or G
subunits and does not undergo any conformational change
upon GTP hydrolysis (34). Taken together, these data suggest
that intracellular targeting of Gpa1 depends on the extent of
ubiquitination. Whereas non-ubiquitinated Gpa1 is retained at
the plasma membrane, monoubiquitinated Gpa1 is delivered
to the vacuole, and polyubiquitinated Gpa1 is delivered to
the proteasome.
DISCUSSION
Ubiquitin is widely recognized as a key regulator of protein
stability. Less understood is how the extent of ubiquitination
affects the behavior of a given substrate. Most known sub-
strates are polyubiquitinated and degraded by the proteasome.
Other substrates are monoubiquitinated, and those substrates
that are integral-membrane proteins are typically delivered to
the vacuole or lysosome. These generalizations hold true for
components of the G protein-signaling cascade. Known targets
of polyubiquitination include mammalian and yeast regulator
of G protein-signaling proteins (13, 36, 37), G protein  sub-
units (Gpa1, transducin) (12, 38), a G protein  subunit (39, 40),
and downstream protein kinases such as Ste7 and MEKK1 (14,
15, 41, 42). In contrast the pheromone receptors in yeast (16,
17) and at least one G protein-coupled receptor in mammals
(43) are monoubiquitinated and delivered to the vacuole or
lysosome. Many receptor-tyrosine kinase growth factor recep-
tors are likewise monoubiquitinated and degraded within the
lysosome. Ubiquitin-dependent endocytosis has also been ex-
ploited by some viruses to down-regulate key molecules of the
host immune system and thereby evade clearance by the host
organism (20).
Together these observations led to the suggestion that ubiq-
uitination is a protein trafficking signal first and a degradation
signal second (20). Whereas monoubiquitination results in traf-
ficking and delivery to the vacuolar compartment, polyubiquiti-
nation results in trafficking to the proteasome. Degradation in
either case depends on delivery to the proper cellular location.
Rigorous proof of this hypothesis would require the ability to
manipulate the extent of ubiquitination of a single substrate
and in so doing determine its route of degradation. In support
of this model we present evidence that Gpa1 is delivered to the
proteasome when polyubiquitinated and is delivered to the
vacuole when monoubiquitinated. If the pool of cellular Gpa1 is
monoubiquitinated and polyubiquitinated, the protein is deliv-
ered to both sites. If Gpa1 cannot be ubiquitinated it is not
delivered to either destination and instead remains at the
plasma membrane.
Our analysis benefited greatly from several unique features
of the experimental system. First, our previous mass spectrom-
etry analysis had revealed that Gpa1 is ubiquitinated at Lys-
165 in vivo (11). This allowed us to design a mutant form of
Gpa1 (Gpa1128–236) that does not undergo ubiquitination. An-
other important advantage was the available crystal structure
of mammalian Gt and Gi proteins, which closely resemble
yeast Gpa1 in both sequence and function (34, 35). Thus, our
Gpa1128–236 mutant could be designed in a rational manner
based on precise knowledge of the position of the ubiquitinated
subdomain within the predicted folded structure of the protein.
Because the ubiquitinated subdomain is not required for G
protein function, it could be deleted without altering known
sites of GTP binding, subunit interaction, receptor coupling, or
membrane association.
Another unique feature of our experimental system is the
ability to manipulate the extent of ubiquitination through the
use of mutants that selectively stabilize mono- or polyubiquiti-
nated substrates. Myc-ubiquitinated proteins are poor sub-
strates for proteolysis and, therefore, accumulate to higher-
than-normal levels within the cell (33). pep4 mutants disrupt
vacuolar protease function and have been successfully used to
enrich monoubiquitinated substrates (16, 17, 30). cim3 mu-
tants disable proteasome protease activity and, therefore, re-
sult in the accumulation of polyubiquitinated substrates (11,
14, 22, 44, 45). Although less commonly applied, ubp mutants
can also be very effective in preserving short-lived changes in
protein ubiquitination. This approach is analogous to using
specific phosphatase inhibitors to preserve transient increases
in protein phosphorylation.
The cellular function of most UBPs is unknown (46), and
none is essential for viability (47). One of the best-character-
ized UBPs is Ubp14, the yeast counterpart of mammalian
isopeptidase T (48, 49) and Drosophila UbpA (49). This enzyme
FIG. 7. Non-ubiquitinated Gpa1 ex-
hibits an increased ability to regu-
late G-mediated signaling. Strain
YGS5 (gpa1 stellts) was transformed
with a single-copy plasmid (pRS316)
containing either the wild-type GPA1
promoter and gene (Gpa1) or a mutant
lacking the ubiquitination subdomain
(Gpa1128 –236) as well as a plasmid
(pRS425-FUS1-lacZ) containing the pher-
omone-induced FUS1 promoter and lacZ
reporter. A, cells were plated onto solid
medium and exposed to paper discs con-
taining -factor pheromone (clockwise
from bottom right: 1, 5, 15, and 45 g) for
48 h. B, cells in mid-log phase of growth
were treated with the indicated concen-
trations of -factor, and the resulting
-galactosidase activity was measured
spectrofluorimetrically. Data shown are
representative of three independent ex-
periments performed in triplicate. Error
bars, S.E. C, to measure protein stabil-
ity the cells were grown to mid-log phase
and treated with the protein synthesis in-
hibitor cycloheximide for the indicated
times. Cells were then collected and re-
solved by 7.5% SDS-PAGE and immuno-
blotting using anti-Gpa1 antibodies. *,
non-specifically recognized species.
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acts primarily on unanchored ubiquitin chains generated as
intermediates in substrate degradation (50). A ubp14 mutant
exhibits a defect in ubiquitin-dependent proteolysis and an
accumulation of unanchored polyubiquitin chains (48, 51, 52).
Another well characterized UBP is Doa4 (Ubp4) (53), which
serves to remove ubiquitin from substrate intermediates dur-
ing the course of proteasomal proteolysis (54). Cells lacking
DOA4 accumulate small polyubiquitinated peptide fragments,
and the consequent depletion of free ubiquitin leads to im-
paired ubiquitination and stabilization of some substrates (54–
57). Depletion of cellular ubiquitin through disruption of DOA4
has been used to document proteasome-dependent degradation
of the effector kinase Ste11 (58) and vacuole-dependent degra-
dation of the a-factor transporter Ste6 (59). A third family
member, Ubp3, is the only UBP isoform that regulates the
pheromone-induced growth arrest and transcription-induction
responses. We previously used a ubp3 mutant to detect the
ubiquitinated form of the effector kinase Ste7 (14, 15). Ubp3
also regulates the ubiquitination of -COP (a subunit of the
COPI coat protein complex) and Sec23 (a subunit of the COPII
complex), which mediate transport between the endoplasmic
reticulum and Golgi compartments (44, 45). Finally, we have
shown here that Ubp12 binds specifically to Gpa1 and regu-
lates Gpa1 ubiquitination. Ubp12 has not been characterized
previously, but a related protein in Schizosaccharomyces
pombe was shown to de-ubiquitinate Pop1. Pop1 is a subunit of
the COP9 signalosome, a multiprotein complex whose role is to
remove the ubiquitin-related peptide NEDD8 (Rub1) from
members of the cullin family of ubiquitin ligases (60).
Of the pheromone-signaling proteins shown to undergo ubiq-
uitination, nearly all are modified in response to pheromone
treatment. Documented examples include the pheromone re-
ceptors Ste2 and Ste3, the regulator of G protein-signaling
protein Sst2, and the effector mitogen-activated protein kinase
kinase Ste7. In contrast, Gpa1 is ubiquitinated in a constitutive
manner independent of pheromone stimulation. Gpa1 abun-
dance is still regulated by pheromone however, since transcrip-
tion is strongly pheromone-induced (2, 61). Moreover, once
mating has occurred, transcription of GPA1 stops altogether.
Thus, although Gpa1 ubiquitination is unaffected by phero-
mone, Gpa1 expression is nevertheless pheromone-regulated.
We believe that a high rate of Gpa1 turnover permits the cell to
tightly regulate expression and rapidly eliminate Gpa1 once
pheromone is removed or mating has occurred successfully.
Another question is why Gpa1 has evolved two separate
mechanisms for degradation. One possibility currently being
tested is that Gpa1 is polyubiquitinated when misfolded, mis-
assembled, or mislocalized. Indeed it has been estimated that
as much as 30% of newly synthesized proteins are incorrectly
made and quickly degraded (62). Conversely, Gpa1 monoubiq-
uitination may occur as part of the normal protein-clearance
process. Stated differently, polyubiquitination could represent
a mechanism for quality control whereas monoubiquitination
places a time limit on the lifetime of the functional protein.
Thus, we have exploited the unique advantages of our exper-
imental system to determine how the extent of ubiquitination
can influence the degradation fate of a single protein. Based on
our data we can propose a model in which Gpa1 is degraded by
two pathways. The first pathway, used by the receptor and G
protein, involves monoubiquitination, endocytosis, and deliv-
ery to the vacuole. The second pathway, also used by Ste7,
involves polyubiquitination and delivery to the proteasome.
This strong relationship between the extent of ubiquitination
and trafficking of the G protein  subunit to its site of degra-
dation establishes a new mechanism of G protein regulation.
More generally, the discovery of a protein that is degraded by
either of two pathways, depending only on the extent of ubiq-
uitination, is to our knowledge unprecedented in any system.
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